GGrantIndex
← Leaderboards

David Oupicky

Wayne State University

Google Scholar ↗PubMed ↗ORCID ↗
$10,225,505
Attributed
$13,817,776
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY2005–23
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$16,105,276 · 15

By mechanism

R01$10,923,287 · 6
P30$3,149,125 · 4
R21$2,032,864 · 5

Top collaborators

Most similar at Wayne State University

Same institution · by research overlap

Others in their field

Top investigators on “Innovation”

Research focus

InnovationDesignBasePropertyNanoparticleParticlePolymersCellsIn VivoIn VitroPharmaceutical PreparationsDrug Delivery SystemsOverexpressionDrug KineticsAffectPublic HealthEncapsulatedEvaluationPathway InteractionsMolecular WeightCombined Modality TherapyPerformanceSmall MoleculeLigands

Grant awards (43)

Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease$517,434
R01 · FY2023 · DK · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$447,493
R01 · FY2023 · CA · contact PI
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease$389,037
R01 · FY2023 · AA · contact PI
Nebraska Center for Nanomedicine$1,143,750
P30 · FY2022 · GM · contact PI
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease$517,434
R01 · FY2022 · DK · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$447,493
R01 · FY2022 · CA · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2022 · DK · contact PI
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease$389,037
R01 · FY2022 · AA · contact PI
Nebraska Center for Nanomedicine$1,143,750
P30 · FY2021 · GM · contact PI
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease$517,434
R01 · FY2021 · DK · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$456,624
R01 · FY2021 · CA · contact PI
Nebraska Center for Nanomedicine- Administrative Core$442,250
P30 · FY2021 · GM · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2021 · DK · contact PI
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease$389,037
R01 · FY2021 · AA · contact PI
Nebraska Center for Nanomedicine- Pilot Projects$343,125
P30 · FY2021 · GM · contact PI
Nebraska Center for Nanomedicine- Nanomaterial Characterization Core$76,250
P30 · FY2021 · GM · contact PI
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease$517,434
R01 · FY2020 · DK · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$456,624
R01 · FY2020 · CA · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2020 · DK · contact PI
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease$389,037
R01 · FY2020 · AA · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$469,749
R01 · FY2019 · CA · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2019 · DK · contact PI
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease$389,037
R01 · FY2019 · AA · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2018 · DK · contact PI
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio$338,625
R01 · FY2017 · EB · contact PI
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio$338,625
R01 · FY2016 · EB · contact PI
Nanoparticles based on histone deacetylase inhibitors for combination treatments$227,254
R21 · FY2016 · EB · contact PI
Dual-function nanoparticles for oral treatment of inflammatory bowel disease$226,742
R21 · FY2016 · EB · contact PI
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio$331,852
R01 · FY2015 · EB · contact PI
Nanoparticles based on histone deacetylase inhibitors for combination treatments$202,504
R21 · FY2015 · EB · contact PI
Dual-function nanoparticles for oral treatment of inflammatory bowel disease$201,313
R21 · FY2015 · EB · contact PI
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio$338,625
R01 · FY2014 · EB · contact PI
Drug-based polycations for combination drug-gene delivery$219,685
R21 · FY2013 · EB · contact PI
Drug-based polycations for combination drug-gene delivery$190,000
R21 · FY2012 · EB · contact PI
Gene Delivery Modulated by Redox Potential Gradients$249,051
R01 · FY2009 · CA · contact PI
Gene Delivery Modulated by Redox Potential Gradients$249,211
R01 · FY2008 · CA · contact PI
Hollow porous silica nanoparticles for targeted drug delivery$219,281
R21 · FY2008 · EB · contact PI
Gene Delivery Modulated by Redox Potential Gradients$249,364
R01 · FY2007 · CA · contact PI
Hollow porous silica nanoparticles for targeted drug delivery$184,138
R21 · FY2007 · EB · contact PI
Gene Delivery Modulated by Redox Potential Gradients$243,195
R01 · FY2006 · CA · contact PI
Synthetic vectors for pH-targeted gene delivery$180,082
R21 · FY2006 · EB · contact PI
Gene Delivery Modulated by Redox Potential Gradients$233,085
R01 · FY2005 · CA
Synthetic vectors for pH-targeted gene delivery$181,865
R21 · FY2005 · EB